Latest News:
  • Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
  • CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
  • BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
  • Nextech AR Signs Poly Deal
  • Ready for New Cannabis and Psychedelics Boom Ahead: CEOs of Aphria, Icanic Brands, Red Light Holland, and Tilray Discuss New Global Market Opportunities

Stock Day Media

Ticker Tape by TradingView

  • News
  • Radio Show
    • Be on our Show!
    • Video Interviews
  • Technology
  • Cannabis
  • Energy
  • BioTech
  • Mining
  • Contact Us
    • About Us
    • Suggestion Box
Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now
Radio Interviews 

Interview from the Stu Taylor Radio Show: CEO Everett Jolly of Uptick Newswire

June 22, 2017June 21, 2017 Marcus Heatherly 423 Views 0 Comments CEO Interviews, Investor Relations, micro cap companies, OTC Exposure, Press Release Distribution, Stock Day Podcast, Stu Taylor
CEO Everett Jolly of Uptick Newswire    CEO Everett Jolly of Uptick Newswire talks with Stu Taylor about the need for Micro Cap Companies to gain media exposure & more.

 

Uptick Newswire staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

 

  • ← Featured Interview: CEO Tom Rossiter of RESAAS Services, Inc. (OTCQX: RSASF)
  • AV1 Group Purchases a 49% Interest in Company That Owns Patented Game-Changing Lighting Technology: A Lightbulb That Could Last 14 Years Burning 24/7 →

You May Also Like

Wrapmail, Inc., CEO Marco Alfonsi Talks about Why Wrapmail Seperates Themselves from their Competition

August 30, 2016 Marcus Heatherly 0

Featured Interview: CEO Andrew Whelan of BioElectronics Corp (OTC Pink BIEL)

April 18, 2017 Marcus Heatherly 0

New Age Beverages CEO, Brent Willis, Announces Uplist to NASDAQ and Release of Two New Beverages

March 15, 2017 Marcus Heatherly 0

Leave a Reply Cancel reply

You must be logged in to post a comment.

Top 5 Penny Stock Picks

Latest News

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
BioTech 

Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

January 15, 2021 Stock Day Media Comments Off on Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange

NEW YORK, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioTech 

CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients

January 15, 2021 Stock Day Media Comments Off on CytRx Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials Yielding Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Patients
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
BioTech 

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

January 15, 2021 Stock Day Media Comments Off on BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
Nextech AR Signs Poly Deal
Technology 

Nextech AR Signs Poly Deal

January 15, 2021 Stock Day Media Comments Off on Nextech AR Signs Poly Deal
Copyright © 2021 Stock Day Media. All rights reserved.